Upcoming UCSF Trial to Evaluate Effectiveness of Three Drugs for PSP
An upcoming clinical trial conducted by the University of California, San Francisco (UCSF) will simultaneously evaluate multiple drugs to determine their effectiveness against progressive supranuclear palsy. The trial has been designed with an emphasis on diverse enrollment and will offer financial support to participants. The study is being funded by a five-year grant of up…
Read MoreFebruary 22, 2025: In-Person Meet & Greet in Sparks, Nev.
AFTD Ambassador Scott Oxarart invites anyone impacted by FTD to join others on the FTD journey for a two-mile walk beginning at Nevada Veterans Memorial Plaza in Sparks (300 Howard Drive), starting at 10:00 a.m. If you are unable to walk, reach out to Scott at soxarart@theaftd.org to find a better way to connect. Download…
Read MoreSparks, Nev. In-Person Meet & Greet
AFTD Ambassador Scott Oxarart invites anyone impacted by FTD to join others on the FTD journey for a two-mile walk beginning at Nevada Veterans Memorial Plaza in Sparks starting at 10:00 a.m. If you are unable to walk, reach out to Scott at soxarart@theaftd.org to find a better way to connect. Download this flyer to…
Read MoreFebruary 9, 2025: Seattle, Wash. Virtual Meet & Greet
Join and learn from others who understand the FTD journey at this virtual AFTD Meet & Greet event for people in Seattle, Wash., and its surrounding communities on Sunday, February 9, starting at 2:00 p.m. PT. Email event host Pooja Thorali at thoralip@uw.edu to RSVP and receive the Zoom link. You can also download this…
Read MoreSeattle, Wash. Virtual Meet & Greet
Join and learn from others who understand the FTD journey at this virtual AFTD Meet & Greet event for people in Seattle, Wash., and its surrounding communities on Sunday, February 9, starting at 2:00 p.m. PT. Email event host Pooja Thorali at thoralip@uw.edu to RSVP and receive the Zoom link. You can also download this…
Read MoreMaking a Difference: AFTD Introduces First-Ever Advocacy Agenda
AFTD has unveiled a robust and ambitious advocacy agenda for 2025, emphasizing the urgent need to better support families facing FTD while pushing for deeper public investments into FTD research and drug development. “This year, AFTD is poised to have a greater impact than ever before in advancing federal and state policies that provide real,…
Read More
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)